aDepartment of Obstetrics & Gynecology, University of British Columbia, Vancouver, Canada;

bWomen's Health Research Institute, Vancouver, Canada; and

cDepartment of Pediatrics, University of British Columbia, Vancouver, Canada.

Correspondence to: Deborah Money, MD, Women's Health Research Institute, C433, 4500 Oak Street, Vancouver, BC V6H 3N1, Canada (e-mail: [email protected]).

No specific funding was secured for this study. The study was supported through the Reproductive Infectious Diseases program at the University of British Columbia Department of Obstetrics and Gynecology.

E.M. receives salary support in the form of postdoctoral fellowships from the Canadian HIV Trials Network/CANFAR and Michael Smith Health Research BC. A.A. is supported by the RANZCOG Jean Murray-Jones Scholarship. C.E. has served as an advisory board member for Gilead, as a reproductive infectious disease specialist. L.S. has research funding from the Public Health Agency of Canada and Women's Health Research Institute (Vancouver, Canada). T.S. has had contact in consultative capacity with ViiV and Gilead Sciences. For the remaining authors, no conflicts of interest were declared.

Presented at the 2023 International Workshop on HIV and Women; February 17–18, 2023; Seattle, WA, United States.